|
US4602035A
(en)
*
|
1983-12-07 |
1986-07-22 |
Hoechst-Roussel Pharmaceuticals Inc. |
Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
|
|
GB8419963D0
(en)
*
|
1984-08-06 |
1984-09-12 |
Lundbeck & Co As H |
Intermediate compound and method
|
|
GB8814057D0
(en)
*
|
1988-06-14 |
1988-07-20 |
Lundbeck & Co As H |
New enantiomers & their isolation
|
|
EP0759299B1
(en)
*
|
1995-08-16 |
2000-04-26 |
Eli Lilly And Company |
Potentiation of serotonin response
|
|
NZ501737A
(en)
*
|
1997-07-08 |
2001-10-26 |
H |
Method for the preparation of citalopram using Grignard reagent 4-halogen-fluorophenyl and 3-halogen-N,N-dimethyl-propylamine
|
|
UA62985C2
(en)
*
|
1997-11-10 |
2004-01-15 |
Lunnbeck As H |
A method for the preparation of citalopram
|
|
SK283907B6
(sk)
|
1997-11-11 |
2004-04-06 |
H. Lundbeck A/S |
Spôsob výroby citalopramu a medziprodukty
|
|
BR9915158B1
(pt)
|
1998-10-20 |
2012-02-22 |
|
método para preparação de citalopram, e, compostos da fórmula geral viii, ix e iv, ou qualquer de seus enantiÈmeros e sais com adição de ácido do mesmo.
|
|
AR021509A1
(es)
*
|
1998-12-08 |
2002-07-24 |
Lundbeck & Co As H |
Derivados de benzofurano, su preparacion y uso
|
|
KR20010081071A
(ko)
|
1998-12-08 |
2001-08-25 |
피터슨 존 메이달 |
벤조푸란 유도체, 그것들의 제조 및 사용
|
|
DK1140886T3
(da)
|
1998-12-23 |
2003-07-28 |
Lundbeck & Co As H |
Fremgangsmåde til fremstilling af 5-cyanophtalid
|
|
AR022329A1
(es)
|
1999-01-29 |
2002-09-04 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-cianoftalida
|
|
CZ296537B6
(cs)
*
|
1999-04-14 |
2006-04-12 |
H. Lundbeck A/S |
Zpusob výroby citalopramu a meziprodukty
|
|
ITMI991581A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991579A1
(it)
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991486A1
(it)
*
|
1999-07-06 |
2001-01-06 |
Vis Farmaceutici S P A |
Processo per la sintesi di citalopram
|
|
AR021155A1
(es)
*
|
1999-07-08 |
2002-06-12 |
Lundbeck & Co As H |
Tratamiento de desordenes neuroticos
|
|
EP1228056B1
(en)
|
1999-10-25 |
2004-09-22 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
TR200401456T1
(tr)
|
1999-10-25 |
2005-04-21 |
H. Lundbeck A/S |
Sitalopram hazırlanması için yöntem.
|
|
AR026063A1
(es)
|
1999-11-01 |
2002-12-26 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-carboxiftalida.
|
|
US6310222B1
(en)
|
1999-11-01 |
2001-10-30 |
Sumika Fine Chemicals Co., Ltd. |
Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
|
|
HUP0203635A3
(en)
*
|
1999-12-28 |
2005-02-28 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
CN1211377C
(zh)
*
|
1999-12-30 |
2005-07-20 |
H.隆德贝克有限公司 |
西酞普兰的制备方法
|
|
ATE252570T1
(de)
*
|
2000-01-14 |
2003-11-15 |
Lundbeck & Co As H |
Verfahren zur herstellung von 5-cyanophthalid
|
|
US6433196B1
(en)
|
2000-02-17 |
2002-08-13 |
Sumika Fine Chemicals Co., Ltd. |
Production method of citalopram, intermediate therefor and production method of the intermediate
|
|
IES20010143A2
(en)
*
|
2000-02-24 |
2001-07-25 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
NL1017415C1
(nl)
*
|
2000-02-24 |
2001-05-18 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
NL1017417C1
(nl)
*
|
2000-03-03 |
2001-03-16 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
GB0005477D0
(en)
|
2000-03-07 |
2000-04-26 |
Resolution Chemicals Limited |
Process for the preparation of citalopram
|
|
IES20010206A2
(en)
|
2000-03-13 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
BR0109176A
(pt)
|
2000-03-13 |
2003-04-22 |
Lundbeck & Co As H |
Método para preparação de citalopram e composto da fórmula
|
|
GB2357762B
(en)
|
2000-03-13 |
2002-01-30 |
Lundbeck & Co As H |
Crystalline base of citalopram
|
|
HUP0300273A2
(hu)
*
|
2000-03-13 |
2003-06-28 |
H. Lundbeck A/S |
Eljárás 5-szubsztituált 1-(4-fluorfenil)-1,3-dihidroizobenzofurán-származékok lépésenkénti alkilezésére
|
|
DK1265882T3
(da)
|
2000-03-14 |
2004-06-01 |
Lundbeck & Co As H |
Fremgangsmåde til fremstilling af citalopram
|
|
TR200202168T2
(tr)
*
|
2000-03-16 |
2002-12-23 |
H. Lundbeck A/S |
5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
|
|
AU2001257022B2
(en)
*
|
2000-04-13 |
2005-02-03 |
Mayo Foundation For Medical Education And Research |
Abeta 42 lowering agents
|
|
US6977306B2
(en)
*
|
2000-05-02 |
2005-12-20 |
Sumitomo Chemical Company, Limited |
Citalopram hydrobromide crystal and method for crystallization thereof
|
|
AR032455A1
(es)
*
|
2000-05-12 |
2003-11-12 |
Lundbeck & Co As H |
Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
|
|
KR100821912B1
(ko)
*
|
2000-05-12 |
2008-04-16 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프람의 제조 방법
|
|
AU2001272368A1
(en)
*
|
2000-07-06 |
2002-01-21 |
H. Lundbeck, A/S |
Method for the preparation of citalopram
|
|
EP1301502B1
(en)
*
|
2000-07-21 |
2005-05-18 |
H. Lundbeck A/S |
Compounds and their use as glycine transport inhibitors
|
|
CA2353693C
(en)
*
|
2000-08-10 |
2003-07-22 |
H. Lundbeck A/S |
Pharmaceutical composition containing citalopram
|
|
FI20011622A
(fi)
*
|
2000-08-18 |
2002-02-19 |
Lundbeck & Co As H |
Menetelmä sitalopraamin valmistamiseksi
|
|
US20030232881A1
(en)
*
|
2000-10-27 |
2003-12-18 |
H. Lundbeck A/S |
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
|
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
|
IT1319686B1
(it)
*
|
2000-12-12 |
2003-10-23 |
C D Farmasint S R L |
Procedimento di preparazione di citalopram.
|
|
CA2360303C
(en)
*
|
2000-12-22 |
2003-08-12 |
Marco Villa |
Process for the preparation of pure citalopram
|
|
DE10164725B4
(de)
*
|
2000-12-28 |
2004-08-26 |
H. Lundbeck A/S |
Verfahren zur Herstellung von gereinigtem Citalopram
|
|
SK284418B6
(sk)
*
|
2000-12-28 |
2005-04-01 |
H. Lundbeck A/S |
Spôsob výroby citalopramu
|
|
DE10112828C1
(de)
*
|
2000-12-28 |
2002-11-21 |
Lundbeck & Co As H |
Verfahren zur Herstellung von Citalopram
|
|
AU2001100195B4
(en)
*
|
2001-01-05 |
2001-12-20 |
H Lundbeck As |
Pharmaceutical composition containing citalopram.
|
|
EP1355897A1
(en)
*
|
2001-01-30 |
2003-10-29 |
Orion Corporation Fermion |
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
|
|
JP2004529883A
(ja)
*
|
2001-02-22 |
2004-09-30 |
ナトコ ファーマ リミテッド |
シタロプラムの調製方法
|
|
GB0105627D0
(en)
|
2001-03-07 |
2001-04-25 |
Cipla Ltd |
Preparation of phthalanes
|
|
CN1221541C
(zh)
*
|
2001-03-09 |
2005-10-05 |
兰贝克塞实验室有限公司 |
制备西酞普兰的方法
|
|
CN1509169A
(zh)
*
|
2001-05-01 |
2004-06-30 |
H��¡�±�������˾ |
对映体纯艾司西酞普兰的用途
|
|
BG65271B1
(bg)
*
|
2001-06-18 |
2007-11-30 |
H. Lundbeck A/S |
Метод за получаване на циталопрам
|
|
AR034759A1
(es)
*
|
2001-07-13 |
2004-03-17 |
Lundbeck & Co As H |
Metodo para la preparacion de escitalopram
|
|
IN192057B
(pl)
*
|
2001-07-19 |
2004-02-14 |
Ranbaxy Lab Ltd |
|
|
JP2005525993A
(ja)
*
|
2001-07-31 |
2005-09-02 |
ハー・ルンドベック・アクチエゼルスカベット |
エスシタロプラムを含む結晶性組成物
|
|
EP1288211A1
(en)
*
|
2001-08-28 |
2003-03-05 |
Sekhsaria Chemicals Ltd. |
Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
US6967259B2
(en)
*
|
2001-09-24 |
2005-11-22 |
Pharmachem Technologies Limited |
Process for the preparation of Citalopram intermediate
|
|
CN101921267A
(zh)
*
|
2001-10-12 |
2010-12-22 |
阿泽范药品公司 |
β-内酰胺后叶加压素V1a拮抗剂
|
|
IN192863B
(pl)
*
|
2001-11-13 |
2004-05-22 |
Ranbaxy Lab Ltd |
|
|
IS7239A
(is)
*
|
2001-12-14 |
2004-04-29 |
H. Lundbeck A/S |
Aðferð til framleiðslu á essítalóprami
|
|
US7148364B2
(en)
*
|
2002-01-07 |
2006-12-12 |
Sun Pharmaceutical Industries |
Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
|
|
GB0204607D0
(en)
*
|
2002-02-27 |
2002-04-10 |
Matrix Lab Ltd |
Process
|
|
GB2385848A
(en)
*
|
2002-02-27 |
2003-09-03 |
Cipla Ltd |
Citalopram salts
|
|
GB2387596B
(en)
*
|
2002-02-27 |
2004-02-11 |
Matrix Lab Ltd |
Process
|
|
EP1346989A1
(en)
*
|
2002-03-21 |
2003-09-24 |
Jubilant Organosys Limited |
Improved process for the preparation of citalopram and its hydrobromide
|
|
WO2003080558A1
(fr)
*
|
2002-03-27 |
2003-10-02 |
Bando Chemical Industries, Ltd. |
Nouveau 1,3,5-tris(arylamino)benzène
|
|
CA2381341A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Torcan Chemical Ltd. |
Process and intermediates for preparing escitalopram
|
|
FI20021421A0
(fi)
*
|
2002-07-30 |
2002-07-30 |
Orion Corp Fermion |
Valmistusmenetelmä
|
|
PE20040991A1
(es)
*
|
2002-08-12 |
2004-12-27 |
Lundbeck & Co As H |
Separacion de intermediarios para la preparacion de escitalopram
|
|
WO2004016602A1
(en)
*
|
2002-08-14 |
2004-02-26 |
Natco Pharma Limited |
Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
|
|
GB2385051B
(en)
*
|
2002-08-29 |
2003-12-24 |
Max India Ltd |
Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
|
|
US6812355B2
(en)
|
2002-10-22 |
2004-11-02 |
Sekhsaria Chemicals Limited |
Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
ATE388947T1
(de)
*
|
2002-12-23 |
2008-03-15 |
Lundbeck & Co As H |
Escitalopramhydrobromid und ein verfahren zu dessen herstellung
|
|
US20050137255A1
(en)
*
|
2002-12-23 |
2005-06-23 |
H. Lundbeck A/S |
Crystalline escitalopram hydrobromide and methods for preparing the same
|
|
WO2004065375A1
(en)
*
|
2003-01-17 |
2004-08-05 |
Natco Pharma Limited |
Processes for the preparation of escitalopram and its precursor
|
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
|
ITMI20030479A1
(it)
*
|
2003-03-13 |
2004-09-14 |
Adorkem Technology S P A |
Procedimento per la preparazione di un ciano-isobenzofurano.
|
|
EP1486492A3
(en)
*
|
2003-06-10 |
2005-02-23 |
Sun Pharmaceuticals Industries Ltd. |
A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
|
|
JP2007528857A
(ja)
*
|
2003-07-11 |
2007-10-18 |
ミリアド ジェネティクス， インコーポレイテッド |
アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
|
|
GB0317475D0
(en)
*
|
2003-07-25 |
2003-08-27 |
Meditab Specialities Pvt Ltd |
Product
|
|
ITFI20030202A1
(it)
*
|
2003-07-28 |
2005-01-29 |
Synteco Spa |
Processo per la preparazione di derivati del
|
|
CN103788089A
(zh)
*
|
2003-09-17 |
2014-05-14 |
詹森药业有限公司 |
作为血清素受体调节剂的稠合杂环化合物
|
|
AU2003278409A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Krishnaji Upadhye Bhargav |
Improved process for the manufacture of citalopram hydrobromide
|
|
ATE293106T1
(de)
*
|
2003-10-28 |
2005-04-15 |
Adorkem Technology Spa |
Verfahren zur herstellung von citalopram
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
US8304431B2
(en)
*
|
2003-12-02 |
2012-11-06 |
Pharmaneuroboost N.V. |
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
ES2515092T3
(es)
|
2003-12-11 |
2014-10-29 |
Sunovion Pharmaceuticals Inc. |
Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
|
|
CN100569765C
(zh)
*
|
2003-12-19 |
2009-12-16 |
杭州民生药业集团有限公司 |
西酞普兰中间体晶体碱
|
|
TWI339651B
(en)
*
|
2004-02-12 |
2011-04-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
|
EP1723133A1
(en)
*
|
2004-02-16 |
2006-11-22 |
Jubilant Organosys Limited |
One pot synthesis of citalopram from 5-cyanophthalide
|
|
US20050196453A1
(en)
*
|
2004-03-05 |
2005-09-08 |
H. Lundbeck A/S |
Crystalline composition containing escitalopram
|
|
ITMI20040717A1
(it)
*
|
2004-04-09 |
2004-07-09 |
Adorkem Technology Spa |
Procedimento chemo-enzimatico per la preparazione dell'escitalopram
|
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
US20050233010A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Satow Philip M |
Lithium combinations, and uses related thereto
|
|
KR20070004036A
(ko)
*
|
2004-04-29 |
2007-01-05 |
키스톤 리테이닝 월 시스템스, 아이엔씨 |
벽, 옹벽 및 그 외 유사한 것을 위한 베니어
|
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
|
US7989645B2
(en)
*
|
2004-08-23 |
2011-08-02 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
|
EP1797060A2
(en)
|
2004-08-23 |
2007-06-20 |
Sun Pharmaceutical Industries Limited |
"process for preparation of citalopram and enantiomers"
|
|
WO2006102308A2
(en)
|
2005-03-22 |
2006-09-28 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin v1b antagonists
|
|
WO2006103550A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Ranbaxy Laboratories Limited |
Processes for the preparation of citalopram and its intermediate 5-aminophthalide
|
|
WO2006116218A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
|
|
US7368477B2
(en)
|
2005-04-22 |
2008-05-06 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof
|
|
AU2006239942A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Dihydrobenzofuran derivatives and uses thereof
|
|
CA2604916A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Dihydrobenzofuran derivatives and uses thereof
|
|
US7834201B2
(en)
|
2005-06-22 |
2010-11-16 |
H. Lundbeck A/S |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
TWI347942B
(en)
|
2005-06-22 |
2011-09-01 |
Lundbeck & Co As H |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
CA2614289A1
(en)
|
2005-07-08 |
2007-01-18 |
Braincells, Inc. |
Methods for identifying agents and conditions that modulate neurogenesis
|
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
AU2006270039B2
(en)
|
2005-07-19 |
2013-07-04 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
|
|
EP1909777A2
(en)
*
|
2005-07-22 |
2008-04-16 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
|
US7598255B2
(en)
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
CN101309924A
(zh)
*
|
2005-11-14 |
2008-11-19 |
H.隆德贝克有限公司 |
依地普仑的制备方法
|
|
GB0601286D0
(en)
|
2006-01-23 |
2006-03-01 |
Sandoz Ag |
Asymmetric synthesis
|
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007104035A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
AU2007231011A1
(en)
*
|
2006-03-24 |
2007-10-04 |
Wyeth |
New therapeutic combinations for the treatment of depression
|
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
|
EP2026813A2
(en)
|
2006-05-09 |
2009-02-25 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
CA2651813A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
WO2008006099A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
|
WO2008059514A2
(en)
*
|
2006-07-31 |
2008-05-22 |
Cadila Healthcare Limited |
Process for preparing escitalopram
|
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
|
EP2068872A1
(en)
*
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100016274A1
(en)
*
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
|
AU2007299920A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
JP4927497B2
(ja)
*
|
2006-10-25 |
2012-05-09 |
株式会社シスコ |
無湿乾燥用ホッパー装置
|
|
CN100457747C
(zh)
*
|
2006-11-21 |
2009-02-04 |
浙江大学 |
抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺
|
|
WO2008083204A2
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc. |
Modulation of neurogenesis by melatoninergic ligands
|
|
WO2008086483A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
DK1988086T4
(en)
|
2007-04-23 |
2015-03-02 |
Synthon Bv |
Method of dissolving citalopram via its (S) -riched citalopram tartrate compound
|
|
WO2008142379A2
(en)
*
|
2007-05-18 |
2008-11-27 |
Cipla Limited |
Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the s-isomer
|
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
|
EP2017271A1
(en)
|
2007-07-06 |
2009-01-21 |
Aurobindo Pharma Limited |
Process for the preparation of escitalopram
|
|
US8022232B2
(en)
*
|
2007-09-11 |
2011-09-20 |
H. Lundbeck A/S |
Method for manufacture of escitalopram
|
|
KR101103118B1
(ko)
*
|
2007-11-02 |
2012-01-04 |
동아제약주식회사 |
신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
|
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
|
EP2116231A1
(en)
|
2008-05-07 |
2009-11-11 |
Hexal Ag |
Granulate comprising escitalopram oxalate
|
|
US20100087664A1
(en)
*
|
2008-10-07 |
2010-04-08 |
Ravindra Vedantham |
Preparation of citalopram and salts thereof
|
|
GR20080100696A
(el)
|
2008-10-23 |
2010-05-13 |
Genepharm �.�. |
Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
AU2010310595B2
(en)
|
2009-10-23 |
2015-07-16 |
Janssen Pharmaceutica Nv |
Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
|
|
PL2587919T3
(pl)
|
2010-07-01 |
2018-05-30 |
Azevan Pharmaceuticals, Inc. |
Sposoby leczenia zespołu stresu pourazowego
|
|
WO2013081567A1
(en)
|
2011-12-02 |
2013-06-06 |
Mahmut Bilgic |
Effervescent antipsychotic formulations
|
|
WO2013100870A1
(en)
|
2011-12-02 |
2013-07-04 |
Mahmut Bilgic |
New antipsychotic compositions
|
|
WO2013110313A1
(en)
*
|
2012-01-23 |
2013-08-01 |
H. Lundbeck A/S |
Selective allosteric modulators of the serotonin transporter
|
|
BR112016022575A2
(pt)
|
2014-03-28 |
2017-08-15 |
Azevan Pharmaceuticals Inc |
Composições e métodos para o tratamento de doenças neurodegenerativas
|
|
MY197558A
(en)
*
|
2016-03-10 |
2023-06-23 |
Janssen Pharmaceutica Nv |
Methods of treating depression using orexin-2 receptor antagonists
|
|
BR112020005107A2
(pt)
|
2017-09-15 |
2020-11-03 |
Azevan Pharmaceuticals, Inc. |
composições e métodos para o tratamento de lesão cerebral
|
|
JP2022540706A
(ja)
|
2019-07-19 |
2022-09-16 |
バイオエクセル セラピューティクス，インコーポレイテッド |
鎮静作用のないデクスメデトミジン治療レジメン
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|